VANTAGRES

DEAD

Serial Number

78435475

Owner

ELAN PHARMA INTERNATIONAL LIMITED

Attorney

Raymond I. Geraldson, Jr.

Filing Date

Jun 15, 2004

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

VANTAGRES Trademark

Serial Number: 78435475

VANTAGRES is a trademark filed by ELAN PHARMA INTERNATIONAL LIMITED on June 15, 2004. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

ELAN PHARMA INTERNATIONAL LIMITED (40 trademarks)

MONKSLAND
ATHLONE CO. WESTMEATH , IE

Entity Type: 99

Legal Representation

Attorney of Record

Raymond I. Geraldson, Jr.

237 trademarks filed View all →

Trademark Details

Filing Date

June 15, 2004

Registration Date

Not Registered

Published for Opposition

October 11, 2005

Goods & Services

Pharmaceutical preparations for the prevention, treatment and diagnosis of inflammatory disorders, diseases and conditions, and for the prevention, treatment and diagnosis of physiological conditions relating to cell adhesion, signaling and migration

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

Mar 13, 2007 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Mar 13, 2007 ABN6

SOU EXTENSION 1 GRANTED

Jun 1, 2006 EX1G

SOU EXTENSION 1 FILED

May 15, 2006 EXT1

PAPER RECEIVED

May 15, 2006 MAIL

NOA MAILED - SOU REQUIRED FROM APPLICANT

Jan 3, 2006 NOAM

PUBLISHED FOR OPPOSITION

Oct 11, 2005 PUBO

NOTICE OF PUBLICATION

Sep 21, 2005 NPUB

LAW OFFICE PUBLICATION REVIEW COMPLETED

Aug 6, 2005 PREV

ASSIGNED TO LIE

Aug 5, 2005 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 3, 2005 CNSA

EXAMINERS AMENDMENT E-MAILED

Aug 3, 2005 GNEA

EXAMINERS AMENDMENT -WRITTEN

Aug 3, 2005 CNEA

AMENDMENT FROM APPLICANT ENTERED

Jul 26, 2005 ACEC

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 19, 2005 CRFA

PAPER RECEIVED

Jul 19, 2005 MAIL

EXAMINER'S AMENDMENT AND/OR PRIORITY ACTION E-MAILED

Jan 18, 2005 GNPE

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

Jan 18, 2005 CPEA

ASSIGNED TO EXAMINER

Jan 18, 2005 DOCK

PAPER RECEIVED

Jul 9, 2004 MAIL

NEW APPLICATION ENTERED

Jun 22, 2004 NWAP

Related Trademarks

More from this Owner

ÉLAN ELAN DRUG TECHNOLOGIES

ELAN DRUG TECHNOLOGIES

ÉLAN ELAN DRUG TECHNOLOGIES

More in Same Class

NAOMI JUDD

SCHWARZ PHARMA